Dataset related to article: Unknown Immunoregulatory Effects of FcRn Inhibition by Efgartigimod in Myasthenia Gravis: A New Mechanism of Action Beyond IgG Reduction
Fuente:
Zenodo
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Recurso digital |
| Published: |
Zenodo
2026
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1866901542590742528 |
|---|---|
| author | Tarasco, Maria Cristina Rinaldi, Elena RITA FRANGIAMORE Vanoli, Fiammetta Berni, Alessia Iacomino, Nicola Canciello, Amalia Andreetta, Francesca Ciusani, Emilio bonanno, silvia Maggi, Lorenzo Baggi, Fulvio Mantegazza, Renato Antozzi, Carlo Cavalcante, Paola |
| author_facet | Tarasco, Maria Cristina Rinaldi, Elena RITA FRANGIAMORE Vanoli, Fiammetta Berni, Alessia Iacomino, Nicola Canciello, Amalia Andreetta, Francesca Ciusani, Emilio bonanno, silvia Maggi, Lorenzo Baggi, Fulvio Mantegazza, Renato Antozzi, Carlo Cavalcante, Paola |
| contents | <p><span>Raw data derived by immunological and molecular analyses performed in myasthenia gravis (MG) patients treated with efgartigimod, an FcRn inhibitor drug, including: i) serum IgG and autoAb quantification by ELISA and RIA; ii) circulating T- and B-cell subpopulation analysis by flow cytometry; iii) gene expression analysis in peripheral blood mononuclear cells (PBMCs) by TaqMan qPCR; iv) FcRn staining in PBMCs by immunofluorescence. </span></p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_19570878 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Dataset related to article: Unknown Immunoregulatory Effects of FcRn Inhibition by Efgartigimod in Myasthenia Gravis: A New Mechanism of Action Beyond IgG Reduction Tarasco, Maria Cristina Rinaldi, Elena RITA FRANGIAMORE Vanoli, Fiammetta Berni, Alessia Iacomino, Nicola Canciello, Amalia Andreetta, Francesca Ciusani, Emilio bonanno, silvia Maggi, Lorenzo Baggi, Fulvio Mantegazza, Renato Antozzi, Carlo Cavalcante, Paola MYASTHENIA GRAVIS, FCRN INHIBITOR, EFGARTIGIMOD, REGULATORY PLASMA CELLS <p><span>Raw data derived by immunological and molecular analyses performed in myasthenia gravis (MG) patients treated with efgartigimod, an FcRn inhibitor drug, including: i) serum IgG and autoAb quantification by ELISA and RIA; ii) circulating T- and B-cell subpopulation analysis by flow cytometry; iii) gene expression analysis in peripheral blood mononuclear cells (PBMCs) by TaqMan qPCR; iv) FcRn staining in PBMCs by immunofluorescence. </span></p> |
| title | Dataset related to article: Unknown Immunoregulatory Effects of FcRn Inhibition by Efgartigimod in Myasthenia Gravis: A New Mechanism of Action Beyond IgG Reduction |
| topic | MYASTHENIA GRAVIS, FCRN INHIBITOR, EFGARTIGIMOD, REGULATORY PLASMA CELLS |
| url | https://doi.org/10.5281/zenodo.19570878 |